ABOUT US
After ten years of research Talos Smart Technology, S.L., established in 2023, represents a significant advancement in the fields of biotechnology and medicine. Its focus on developing an automated method for the cultivation of CAR-T cells is particularly noteworthy. CAR-T cells are a type of cell therapy that has shown promise in treating certain types of cancer. These cells are genetically modified to more effectively target cancer cells.
The use of artificial intelligence and small-scale bioreactors based on microfluidic principles is an innovative approach. Microfluidics, which involves the control and manipulation of liquids at very small scales, can allow for more efficient and controlled cultivation of CAR-T cells. This could improve the quality and efficiency of producing these therapeutic cells.
Breaking Barriers in Cancer Care
Talos Smart Technology’s mission to improve and make cancer therapies more accessible is commendable. The multidisciplinary team, which includes specialists in cancer, CAR-T cells, microfluidics, and biology, as well as experts in startup development and business in the healthcare sector, is essential for addressing the complex challenges in medical innovation and the implementation of new technologies.
This combination of technical expertise and focus on accessibility could position Talos Smart Technology as a leader in the field of cell therapy and innovation in cancer treatment. Their work has the potential to significantly contribute to the fight against cancer, enhancing current therapies and making them more accessible to a wider range of patients.
Pioneering Global Health Solutions
Our company is driven by a relentless pursuit of scientific excellence to elevate the quality of life worldwide. We’re dedicated to translating innovative discoveries into practical solutions for patient care, forging partnerships, and nurturing creative minds to advance healthcare for the benefit of all.
We are a catalyst for health innovations, leveraging the latest in scientific research to empower groundbreaking solutions. Our collaborative ecosystem unites experts and pioneers, fostering technological breakthroughs that lead to improved health outcomes on a global scale.
Revolutionizing Biopharmaceuticals
We stand at the forefront of biopharmaceutical research, facilitating the swift translation of scientific breakthroughs into effective patient care, all while fostering a dynamic community of visionaries dedicated to enhancing global health.
Our company is dedicated to pioneering innovative solutions at the forefront of biopharmaceutical technology. Our flagship product is a groundbreaking automated cell culture system designed to revolutionize T cell growth optimization. Leveraging state-of-the-art image analysis technology, our system continuously monitors T cell cultures within microfluidic bioreactors, providing real-time insights into cell growth dynamics.
Innovating Cell Therapy
Our cutting-edge artificial intelligence system analyzes captured images, precisely measuring cell occupancy, and employs reinforcement learning to dynamically control pumps and flow parameters, creating a self-regulating feedback loop. This seamless integration of machine learning and microfluidic technology ensures precise control over critical factors such as medium composition and renewal schedules, all in real-time.
The result is a highly efficient, cost-effective process that enables the production of personalized autologous cell therapies. By automating and fine-tuning every aspect of the cell culture process, we reduce errors, save time, and significantly lower production costs. Our platform represents a paradigm shift in CAR T treatment, offering improved feasibility, viability, and faster production of modified cells tailored to individual patients’ needs.
OUR MISSION
Empowering Cancer Treatment
Our mission is to harness the power of AI and microfluidic technology to revolutionize the cultivation and application of CAR-T cells, making advanced cancer therapies more effective, efficient, and accessible to all patients in need
Innovating for Healthier Futures
We are committed to pushing the boundaries of biotechnology and healthcare by innovating in the field of CAR-T cell therapy. Our goal is to provide groundbreaking, affordable treatments for cancer patients, while continuously advancing our research to stay at the cutting edge of medical science.
Bridging Technology and Care
Talos Smart Technology is dedicated to bridging the gap between advanced technology and patient care. We aim to develop and implement AI-enhanced, microfluidics-based solutions for the cultivation of CAR-T cells, focusing on improving the quality of life for cancer patients through more personalized and effective treatments.
OUR VISION
Revolutionizing Cancer Therapy:
To be at the forefront of biotechnological innovation, transforming the landscape of cancer treatment through cutting-edge CAR-T cell therapies and AI-driven solutions, ultimately aiming to turn cancer into a manageable, chronic condition rather than a life-threatening disease.
Pioneering Accessible Healthcare Innovations:
Our vision is to pioneer a future where advanced cancer treatments, such as CAR-T cell therapies, are universally accessible, breaking down barriers in healthcare and providing hope and healing to every cancer patient, regardless of their background or circumstances
Leading in Personalized Medicine:
To lead the evolution of personalized medicine by leveraging our expertise in microfluidics and AI, developing customized, efficient, and effective CAR-T cell therapies that cater to the unique needs of each cancer patient, thereby setting a new standard in precision oncology.
Pipeline – Decentralization in CAR-T Therapy
PARTNERS
